Loading…
Formology Lab Inc., a pharmaceutical drug manufacturer in Chatsworth, California, was cited for significant Current Good Manufacturing Practice (CGMP) violations following an FDA inspection in August-September 2022. The company failed to conduct identity testing on Active Pharmaceutical Ingredients (API) before using them in drug manufacturing, resulting in multiple drug product batches being manufactured and released without scientific evidence that incoming components met required specifications. The firm's corrective action response was deemed inadequate because it lacked specific implementation timelines and sufficient detail for the enhanced component testing procedures.